I-06 Cannabidiol for Management of Acute Dental Pain
CE Hours: 1.0
Description: Cannabidiol (CBD) is a primary cannabinoid that has shown great promise as an analgesic alternative. This talk will present the most up-to-date data on the use of cannabidiol (CBD) for managing dental pain.
Learning Objectives:
- Evaluate the current preclinical and clinical evidence on CBD for dental and orofacial pain, including efficacy, dosing considerations, safety profile, and limitations of existing studies.
- Describe biological mechanisms by which cannabidiol (CBD) modulates dental pain, with emphasis on peripheral and central nociceptive pathways.
- Discuss the potential clinical implications of CBD as a non-opioid adjunct for dental pain management, highlighting opportunities, challenges, regulatory considerations, and future directions for endodontic and dental practice.
Key:
Complete
Next
Failed
Available
LockedVanessa Chrepa, D.D.S., M.S.
Dr. Vanessa Chrepa was born and raised in Athens, Greece. She received her DDS from the University of Athens School of Dentistry. She completed her residency and Master's in Endodontics at UT Health San Antonio with a full scholarship from the Onassis Foundation. Later, she received a PhD in Translational Science from UTSA. She is currently an Associate Professor and Director of Clinical and Translational Research in the Endodontics and Oral Biology departments at Rutgers School of Dental Medicine. Dr. Chrepa is a Diplomate of the American Board of Endodontics and a full-time educator for 10 years. In 2017, she received the AAE Educator Fellowship Award for her academic accomplishments. Her research interests include regenerative endodontics, stem cell biology, endodontic outcomes, and cannabinoids for dental pain. She is a member and past chair of the AAE Regenerative Endodontics Committee. She is an Editorial Review member for the Journal of Endodontics and International Endodontic Journal, among others. Alongside her teaching and research, Dr. Chrepa maintains a private practice limited to Endodontics.
Disclosure(s): No financial relationships to disclose